• No Post Treatment Scars

    Non-invasive therapy requires no incisions or needles, eliminating surgical wounds and significantly reducing infection risk, bleeding, and downtime.

  • Precise, Targeted Treatment

    Advanced technology targets and destroys tumor tissue with precise accuracy, preserving surrounding organs and vital structures.

  • Faster Recovery Time

    With no surgical trauma and minimal impact on healthy tissue, faster recovery, less discomfort, and a quicker return to normal life.

Find the right cancer treatment

MediChoice helps patients access non-invasive liver cancer treatment and clinical trials in Hong Kong. We match you instantly with the right hospitals and treatments — based on your diagnosis.

Even if you’re not eligible for non-invasive treatment, we help match you with ongoing clinical trials in Hong Kong & Asia.

Check Eligibility for Histotripsy
  • Early Stage (BCLC 0–A)

    Ideal for small, localised liver tumors. Non-invasive option for patients seeking precise tumor destruction without surgery or heat.

  • Intermediate Stage (BCLC B / Multiple lesions)

    Suitable for larger or multiple tumors when each lesion is safely targetable. Helps control tumor growth with minimal damage to healthy liver.

  • Advanced Stage With Vascular Invasion (BCLC C)

    Can treat select advanced cases, including tumors with portal-vein or vascular invasion, if the target is accessible and liver function is stable.

  • Other Types of Cancer (Clinical Trials)

    Histotripsy is now in clinical trials for multiple metastatic cancers, including breast and prostate.

How does MediChoice work?

Step icon

Step 1: Form

Fill out our 1-minute Pre Qualification Form

We will start with a few questions about you and why you are interested in histotripsy. All data you provide is protected and not shared.

Step icon

Step 2: Data mapping

Proccessing

We will collect information to better provide a recommendation on whether you qualify for a Histotripsy Procedure, or if you have other options.

Step icon

Step 3: Email

Recommendation

We will send you an email with either the hospitals that provide the treatment, including their price packages. And if you don't qualify for a histotripsy right now, we will send you a list of relevant clinical trials and how you can register.

Step icon

Step 4: Connection

Connect with hospitals or Clinical Trials

We will send you an email with either the hospitals that provide the treatment, including their price packages. And if you don't qualify for a histotripsy right now, we will send you a list of relevant clinical trials.

  • 100% Free Pre-Assessment

  • Private & Secure (HIPAA-Grade Encryption)

  • GDPR Compliant

  • Trusted by Top Hospitals in Hong Kong

3,478 Treatment Matches

MediChoice helped to find the right cancer treatment and clinical trials

Supported by

  • Hong Kong Pioneers Multimodal Focal Therapy for…

    Hong Kong – In a significant medical breakthrough, The Chinese University of Hong Kong (CUHK) has established itself as a pioneer in Asia by introducing and systematically evaluating multimodality focal…

    Read more 
  • Li Ka Shing Foundation Brings Groundbreaking No…

    Hong Kong has made medical history as the first region in Asia to deploy cutting-edge histotripsy technology for liver cancer treatment, following a landmark donation from the Li Ka Shing...

    Read more 
  • Hong Kong Establishes itself as Asian Pioneer i…

    HONG KONG – Hong Kong has solidified its position as Asia’s leading center for innovative non-invasive cancer treatment, becoming the first region in Asia to deploy revolutionary Histotripsy technology for clinical…

    Read more 
1 of 3